BETHLEHEM, Pa., May 5, 2010 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced revenues of $17.9 million for the three months ended March 31, 2010, compared to $17.3 million recorded for the three months ended March 31, 2009. Increased sales of cryosurgical systems products and higher licensing and product development revenues were partially offset by lower revenues from the Company’s infectious disease testing and insurance risk assessment businesses. Revenues in the current quarter include a $1.0 million milestone payment that was received under the terms of a collaboration agreement for the development and promotion of the Company’s OraQuick® rapid HCV test.
